• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problems Chest Pain (1776); Non specific EKG/ECG Changes (1817); Thrombosis/Thrombus (4440)
Event Date 11/28/2022
Event Type  Injury  
Event Description
It was reported that thrombus occurred.A 2.75x38mm and 2.75x16mm synergy xd balloon expandable stents were implanted in the proximal mid left anterior descending (lad) artery.The stents were posy dilated with a nc emerge 3.0x15mm balloon catheter.The patient was given up to 14,000 units of heparin during the initial implant procedure but could not achieve and act over 250.The stent implants went well.After 1 hour in the post procedural recovery area, the patient began to have severe chest pain and show st elevations in the ekg.The patient was returned immediately to the cath lab procedure room and was found to have occluded lad artery with thrombus.An additional 10,000 units of heparin was administered, and the patient act was drawn and was found to be therapeutic at 408.A larger post-dilatation balloon of 4.0x12 mm and expanded the stents once more.Timi iii flow was achieved, and the chest pain and ekg changes were resolved.The patient was then placed on aggrastat for a few hours and was transferred to another hospital where the patient was observed for 48 hours, and patient was discharged.The patient is expected to make a full recovery with no lasting damage from this incident.
 
Event Description
It was reported that thrombus occurred.A 2.75x38mm and 2.75x16mm synergy xd balloon expandable stents were implanted in the proximal mid left anterior descending (lad) artery.The stents were post dilated with a nc emerge 3.0x15mm balloon catheter.The patient was given up to 14,000 units of heparin during the initial implant procedure but could not achieve and act over 250.The stent implants went well.After 1 hour in the post procedural recovery area, the patient began to have severe chest pain and show st elevations in the ekg.The patient was returned immediately to the cath lab procedure room and was found to have occluded lad artery with thrombus.An additional 10,000 units of heparin was administered, and the patient act was drawn and was found to be therapeutic at 408.A larger post-dilatation balloon of 4.0x12 mm and expanded the stents once more.Timi iii flow was achieved, and the chest pain and ekg changes were resolved.The patient was then placed on aggrastat for a few hours and was transferred to another hospital where the patient was observed for 48 hours, and patient was discharged.The patient is expected to make a full recovery with no lasting damage from this incident.It was further reported that the lesion was 80% stenosed with mild calcium and not tortuous.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15928383
MDR Text Key304954620
Report Number2124215-2022-51077
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age71 YR
Patient SexMale
-
-